Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2026 07:20 ET | Source: Precedence Research

Maternal Nutrition Market Size to Surpass USD 70.36 Billion by 2035, Driven by Preventive Healthcare and AI-Led Innovation

Ottawa, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The global maternal nutrition market size stood at USD 33.20 billion in 2025 and is predicted to grow from USD 35.79 billion in 2026 to reach around USD...
November 27, 2025 12:00 ET | Source: MCI, LC

MCI Taps FEMA/DHS Veteran Executive Mark Misczak as President; Spins Out Tier-5 AiCX.com Division

CX CONGLOMERATE MCI TAPS FEMA/DHS VETERAN EXECUTIVE MARK MISCZAK AS PRESIDENT; SPINS OUT TIER-5 AiCX.COM DIVISION
November 10, 2025 09:00 ET | Source: AnaptysBio, Inc.

Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis

Rosnilimab was safe and well tolerated with similar adverse event rates vs. placeboObserved expected pharmacology, including ~90% depletion of pathogenic T cells, however lack of adequate efficacy at...
November 07, 2025 07:22 ET | Source: Research and Markets

Trends & Strategies Shaping the $65.5 Billion Managed Mobility Services (MMS) Market, 2025-2030 - Industry Growth Driven by Rise of Hybrid Work and Mobile Endpoint Proliferation

Dublin, Nov. 07, 2025 (GLOBE NEWSWIRE) -- The "Managed Mobility Services (MMS) - A Global Market Overview" has been added to ResearchAndMarkets.com's offering. The global Managed Mobility...
November 04, 2025 16:15 ET | Source: AnaptysBio, Inc.

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update

Announced intent to separate biopharma operations from substantial royalty assets by YE 2026Phase 2 top-line data through Week 12 for rosnilimab, a pathogenic T cell depleter, in ulcerative colitis on...
November 04, 2025 09:00 ET | Source: WidePoint Corporation

WidePoint Secures an Estimated $40 Million to $45 Million SaaS Contract to Deliver FedRAMP-Authorized ITMS™ Command Center Platform for Leading Global Telecom Carrier

FAIRFAX, Va., Nov. 04, 2025 (GLOBE NEWSWIRE) -- WidePoint Corporation (NYSE American: WYY), a federally certified provider of Trusted Mobility Management (TM2) solutions, is proud to announce a...
October 30, 2025 12:13 ET | Source: FullPAC, Inc.

RoboCent Launches “2026 Midterm” Platform Upgrade

VIRGINIA BEACH, VA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- FullPAC, Inc., (“FullPAC” or the “Company”), a leading nonpartisan campaign technology provider trusted by over 5,000 political organizations...
October 28, 2025 08:05 ET | Source: Maestra

Maestra.io Launches Shopify Loyalty App as It Emerges as the Leading Klaviyo Alternative

Arlington, MA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Maestra.io, the all-in-one, real-time, CDP-powered marketing platform for direct-to-consumer brands, today announced the launch of its Shopify...
October 24, 2025 08:02 ET | Source: Janssen Cilag International NV

TREMFYA® (guselkumab) receives European Commission approval for subcutaneous induction through to maintenance in adults with ulcerative colitis, now the first IL-23 inhibitor with a fully subcutaneous dose regimen

Guselkumab offers the flexibility of self-administration from the start of treatment in both ulcerative colitis (UC) and Crohn’s disease (CD),1,2,3 providing the simplicity of a fully subcutaneous...
October 21, 2025 08:44 ET | Source: Breakthrough Women in Science & Medicine

Breakthrough Women in Science & Medicine episode addresses the obesity epidemic — Premiering on PBS, November 1st

The November 1st episode addresses obesity misconceptions, the classification of obesity as a chronic disease, weight bias, and GLP-1s and surgery options.